SANG
Sangoma Technologies Corporation
There isn't enough reported data to score SANG yet.
SANG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Under pressure |
SANG's profitability and balance sheet are currently under pressure. There isn't enough data to rate its revenue and cash flow.
SANG PE Valuation
SANG has no meaningful PE right now: it lost money over the past year.
SANG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| -- | |
| Limited | |
| -- |
Analysts expect SANG's losses to shrink, with revenue holding steady.
SANG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$0.15 | +$0.11 |
| Q2 2024 | -$0.26 | +$0.62 |
| Q2 2023 | -$0.88 | +$2.64 |
| Q2 2022 | -$3.52 | -7140% |
| Q2 2021 | $0.05 | -80% |
| Q1 2021 | $0.27 | +17% |
| Q4 2020 | $0.49 | +123% |
| Q3 2020 | $0.29 | 0% |
SANG has swung to a loss: it lost $0.15 per share over the past year, after a profit the year before.
SANG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $236.7M | -4.3% |
| Q2 2024 | $247.3M | -2.1% |
| Q2 2023 | $252.5M | +13% |
| Q2 2022 | $224.4M | +524% |
| Q2 2021 | $36M | +82% |
| Q1 2021 | $19.7M | +9.2% |
| Q4 2020 | $19M | +9.6% |
| Q3 2020 | $18.4M | +24% |
SANG's revenue has grown year over year for 21 quarters in a row: $237M last quarter, up 558% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -2.7% | +0.9 points |
| Q2 2024 | -3.8% | -12 points |
| Q2 2023 | -13% | -23 points |
| Q2 2022 | -47% | -56 points |
| Q2 2021 | -3.6% | -12 points |
| Q1 2021 | 8.4% | -0.3 points |
| Q4 2020 | 10% | +2.8 points |
| Q3 2020 | 9.7% | +3.9 points |
SANG's operating margin was −2.7% last quarter, up 0.9 points from the same quarter a year ago.
SANG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $39.4M | -1.8% |
| Q2 2024 | $40.1M | +79% |
| Q2 2023 | $22.5M | +17% |
| Q2 2022 | $19.2M | +570% |
| Q2 2021 | $2.9M | -48% |
| Q1 2021 | $1.7M | +83% |
| Q4 2020 | $3.4M | +$5.4M |
| Q3 2020 | $1.7M | +33% |
SANG generated $121M in free cash flow over the past year, more than ten times what it generated the year before.
SANG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 2.9x | Moderate |
| Q1 2021 | 4.1x | High |
| Q4 2020 | -1.6x | Net Cash |
| Q3 2020 | -1.7x | Net Cash |
| Q2 2020 | 2.0x | Healthy |
| Q1 2020 | 2.7x | Moderate |
| Q4 2019 | 3.1x | Elevated |
| Q3 2019 | 0.3x | Very low |
SANG's net debt is about 2.9 years of its operating earnings (EBITDA), up from 2.0 years a year ago.
SANG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.1 | Neutral |
| Stochastic | 76.3 | Neutral |
SANG's weekly RSI is 61 (neutral) and its Stochastic is 76 (neutral).
SANG PE vs Technology Sector
| Metric | SANG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
SANG has no meaningful PE right now: it lost money over the past year.
SANG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.60 | 3.7% above |
| 20 week MA | $4.18 | 14% above |
| 50 week MA | $4.29 | 11% above |
| 100 week MA | $4.98 | 4.2% below |
| 200 week MA | $4.63 | 3% above |
SANG's trend is mixed: it's above four of its five weekly moving averages, and 3% above its 200-week average.
SANG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.3 | $18.1 | +36% |
| 2021 | $18.1 | $16.7 | -7.7% |
| 2022 | $16.7 | $3.79 | -77% |
| 2023 | $3.79 | $3.20 | -16% |
| 2024 | $3.20 | $7.00 | +119% |
| 2025 | $7.00 | $5.03 | -28% |
| 2026 YTD | $5.03 | $4.77 | -5.2% |
SANG's yearly returns have swung widely, from +119% in 2024 to −77% in 2022. It's down 5.2% so far in 2026.